Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Patent Trial and Appeal Board
Pharma
Mylan challenge to Novo's Victoza results in PTAB review
The U.S. Patent Trial and Appeal Board agreed to review of a patent for Novo Nordisk's Victoza after a challenge from generics maker Mylan.
Eric Sagonowsky
Jun 24, 2020 11:44am
Alexion's Soliris gets a reprieve with Amgen biosim settlement
Jun 1, 2020 11:31am
Court rejects Allergan's tribal licensing strategy
Jul 23, 2018 11:27am
J&J's blockbuster Zytiga faces 2018 generic threat
Jan 18, 2018 10:31am
Novartis' MS med Gilenya falls in patent appeal
Apr 13, 2017 10:51am
Biogen triumphs in latest Tecfidera patent dispute
Apr 3, 2017 12:12pm
